Global Automatic Cell Imaging System Market - 2024-2031

Global Automatic Cell Imaging System Market - 2024-2031

The global automatic cell imaging system market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

Automated image analysis employs software to isolate data from digital images. Algorithms identify specific shapes and patterns in the pictures and compile quantitative information that is then utilized in cell imaging studies of cellular structure and function in cells. It enables the visualization and quantitation of dynamic cellular processes in real time.

Live-cell imaging is a microscopy-based technique used to examine living cells in real-time. Automated time-lapse microscopy provides unique research opportunities to visualize cells and subcellular components in experiments with time-dependent parameters. Only recently have the use of an environmentally controlled chamber and robotic stage controllers allowed for high-throughput continuous imaging over long periods at the cell and subcellular levels. Numerous automated imaging systems are now available from both companies that specialize in live cell imaging and from major microscope manufacturers.

Market Dynamics: Drivers

Technological Innovations and Increased Research Initiatives & Investments by Governments

The demand for the automatic cell imaging system market is driven by multiple factors. As life sciences and biomedicine studies advance, they become more sophisticated and require automated technology to maintain the data throughput necessary for scientific advancement. Microscopic imaging of biological processes is a fundamental data acquisition and analysis technique used in biomedical research.

Therefore, the growing research initiatives and funding in biomedicine boost the global automatic cell imaging system market. For instance, the independent ISREC Foundation focused on supporting innovative cancer research in Lausanne and Western Switzerland, particularly translational oncology which is guaranteed to impact the future treatment of cancer patients positively.

Similarly, in July 2021, the Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to saving more lives through the discovery and development of potent immunotherapies for all cancers, reported that it had awarded more than $28.5 million in research grants and fellowships during the 2021 fiscal year ending June 30, 2021. Thus, the increased research initiatives and findings for biomedicines are boosting the growth of the global automatic cell imaging system during the forecasted period.

Moreover, key players in the industry introduce new products and launches propel this market growth. For instance, in January 2023, ZEISS is introducing its new all-in-one cell imaging system. ZEISS Axiovert 5 digital uses artificial intelligence (AI) and automatic functions to ease daily work in the cell lab. From scientific routine to basic research, from phase contrast to multichannel fluorescence imaging, processes become more efficient and results more reproducible. The system comes with an intuitive operating concept. Even novice users are guaranteed to produce brilliant images with ZEISS Axiovert 5 digital. Settings or adjustments take place automatically.

Restraints

Factors such as the high cost of the instrument, operational complexity of the system, limited sample size, regulatory compliance, data security issues, limited availability of skilled professionals, and lack of awareness are expected to hamper the market.

Segment Analysis

The automatic cell imaging system market is segmented based on type, technology, application, end-user, and region.

The live cell and in vivo imaging segment accounted for approximately 53.4% of the automatic cell imaging system market share

The live cell and in vivo imaging segment is expected to hold the largest market share over the forecast period. This is because of the new product introductions by various market payers. For instance, in September 2021, PHC Corporation of North America and Screen Holdings Co., Ltd partnered to market the Screen Cell Imager series of live cell imaging systems in North America.

Additionally, in April 2022, CytoSMART technologies introduced the Omni FL, a new live-cell imaging analysis system containing red and green fluorescence channels, into its signature Omni product line for the first time.

Furthermore, in June 2021, Leica Microsystems introduced its Leica Nano workflow, a brand new live-cell correlative light and electron microscopy (CLEM) workflow solution developed to improve experimental success rates, reproducibility and simplify light and electron microscopy (EM) integration. Thus, the increasing product introduction for live cell and in vivo imaging ensures its dominance over the global automatic cell imaging system market during the forecast period.

Moreover, next-generation technologies such as AI incorporation in the cell imaging system drive this market growth. For instance, in September 2023, Nikon Corporation announced the release of the smart imaging system ECLIPSE Ji, which utilizes AI to automate the acquisition and analysis of cellular images, streamlining research workflows involving cancer and nerve disease.

The smart imaging system ECLIPSE Ji, a digital inverted microscope, will go on sale from September 8th. The ECLIPSE Ji features a microscope design without eyepieces. Combining this hardware with the NIS-Elements SE imaging software will enable standardized assays that perform image acquisition, analysis, and data display.

Also in, February 2024, Tecan takes pride in providing end-to-end cellomics workflow solutions, ranging from drug dosage and live-cell imaging and analysis to cell seeding and culture with quality control and monitoring. With the help of an all-inclusive solution, labs may enhance the consistency, repeatability, and productivity of their processes, tackling major issues in the rapidly expanding field of 3D cell biology.

Geographical Analysis

North America accounted for approximately 42.6% of the automatic cell imaging system market share

North America region is expected to hold the largest market share over the forecast period. owing to increasing initiatives by the government toward biomedical research. For instance, according to the American Association for the Advancement of Science, Congress created the Advanced Research Projects Agency for Health (ARPA-H), provided around $1 billion for startup investment, and has plans to offer $6.5 billion in funding.

Furthermore, most of the key market players, such as Axion BioSystems, BD, BioTek Instruments, and Thermo Fisher Scientific, hold the majority of market share through various market strategies, ensuring the growth of the North American automatic cell imaging systems.

In this region, key players' strategies such as partnerships and collaborations drive this market growth. For instance, in May 2023, Neu-tec Group Inc. was pleased to announce its new distribution partnership with DK-based Biosense Solutions. The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development. It uniquely tracks the growth of microorganisms in multi-well plates by combining microscopic imaging with automated time-lapse photography.

For instance, in January 2023, Axion BioSystems, a leading life sciences tools company focused on advanced live-cell assay systems, acquired the Netherlands-based CytoSMART Technologies, an innovator in kinetic live-cell imaging analysis. Thus, the data above indicates that North America will hold most of the global automatic cell imaging systems market throughout the forecasted period.

COVID-19 Impact Analysis

The COVID-19 has positively impacted the global automatic cell imaging system market since post-COVID, and increased investments in biomedical research have been made. In February 2022, Olympus Life Science stated that the VS200 slide scanner has proven to be a powerful imaging device to study COVID-19 infections in cells and tissues. The system can be used to visualize and evaluate lung damage from tissue sections obtained from infected subjects (human, mice, etc.) under different conditions. It can also be used to locate and quantify COVID-19 infection in cells or tissue.

Also, in NCBI research publication in October 2022, stated that COVID-19 screening using the intra-patient population distributions of bio-optical attributes extracted from digital holographic microscopy reconstructed red blood cells. Whereas previous approaches have aimed to identify infection by classifying individual cells, here, we propose an approach to incorporate the attribute distribution information from the population of a given human subjects’ cells into our classification scheme and directly classify subjects at the patient level.

In addition, estimates suggest changes in growth rates across the public-private sector R&D ecosystem, but it is likely these changes predominantly reflect the reaction to, and effect of, the COVID-19 pandemic.

Market Segmentation

By Type
• Computer Controlled Type
• Touch Screen Operate Type

By Technology
• Fluorescence
• Luminescence
• Phase Contrast
• Others

By Application
• Live Cell and In Vivo Imaging
• Screening
• Others

By End-Users
• Hospitals and Clinics
• Research Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the automatic cell imaging system market include Thermo Fisher Scientific, Axion BioSystems, Leica Microsystems, GE Healthcare Life Sciences, Olympus, BD, Agilent Technologies, Inc., PerkinElmer Inc., Oxford Instruments, and HORIBA Medical among others.

Key Developments

 On February 7, 2024, in separate transactions, Bruker acquired preclinical in-vivo optical imaging systems company Spectral Instruments Imaging (SII), and Nanophoton Corporation, a provider of advanced research Raman microscopy systems.

 On October 16, 2023, Molecular Devices, LLC., a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation, launched the CellXpress.ai Automated Cell Culture System—an end-to-end, machine learning-enabled solution that automates demanding feeding and passaging schedules with an integrated incubator, liquid handler, and imager, giving scientists more time and autonomy in the lab.

 On May 25, 2023, Thermo Fisher Scientific partnered with BRIN to enhance research capabilities in Indonesia. Leveraging its expertise and portfolio, Thermo Fisher will aid BRIN in bolstering research competencies and capacities, aligning with BRIN's goal of advancing scientific research infrastructure.

 On February 1, 2023, Nikon unveiled the Nikon Spatial Array Confocal Detector (NSPARC), designed exclusively for the AX confocal series. NSPARC employs an ultra-low noise detector array to capture two-dimensional images at each scanning point, promising super-resolution capabilities for enhanced imaging.

 On January 5, 2023, Bruker Corporation announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy. The advanced fluorescence microscopy imaging solutions of Bruker, like light-sheet and super-resolution microscopy technologies, which generate high information content, are enhanced by this purchase by adding high-performance on-premise processing, secure storage, and networking technology.

 On January 4, 2023, Biognosys and Bruker joined forces to provide advanced proteomics CRO services to global biopharma and biomarker customers. Through this collaboration, more people will be able to access Spectronaut software tools and Biognosys' CRO services, facilitating objective proteomics and epiproteomics research.

Why Purchase the Report??
• To visualize the automatic cell imaging system market segmentation based on type, technology, application, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of automatic cell imaging system market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.

The automatic cell imaging system market report would provide approximately 70 tables, 64 figures, and 181 Pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies